Related Experiment Videos
An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation
1Department of Biochemistry and Biophysics, University of California Medical Center, San Francisco 94143-0502.
Journal of Virology
|June 1, 1993
Summary
Hepatitis B virus (HBV) RNA packaging relies on the epsilon signal. Specific structures within epsilon, like stems and loops, are crucial for efficient HBV encapsidation, with sequence important in some regions but not others.
Area of Science:
- Virology
- Molecular Biology
- RNA Biology
Background:
- Selective encapsidation of hepatitis B virus (HBV) genomic RNA into core particles is essential for viral replication.
- This process is mediated by a cis-acting element known as epsilon (ε), located at the 5' end of the viral RNA.
Purpose of the Study:
- To map the minimal functional region of the HBV epsilon signal.
- To elucidate the secondary structure of the epsilon element.
- To investigate the role of specific structural features and sequences within epsilon in RNA encapsidation.
Main Methods:
- Transfection of plasmids expressing chimeric RNAs (HBV-lacZ fusions).
- Mapping of the minimal epsilon region using functional assays.
- Enzymatic probing to determine RNA secondary structure.
- Site-directed mutagenesis to assess the impact of mutations on encapsidation in vivo.
Main Results:
- The minimal epsilon region was mapped to the 5' 94 nucleotides of the HBV genomic RNA.
- Enzymatic probing revealed a stem-loop structure within epsilon, featuring a lower stem, a 6-nt bulge, an upper stem with a single unpaired U, and a 6-nt loop.
- Mutational analysis demonstrated that base pairing in the lower stem is critical, while specific sequences in the loop and upper stem are essential for efficient RNA encapsidation.
Conclusions:
- The secondary structure of the HBV epsilon signal is critical for selective RNA encapsidation.
- Specific sequence elements within the epsilon loop and upper stem are vital for function.
- Understanding these structural requirements can inform strategies targeting HBV replication.